Clinical Trials Asia Summit
2010
19, 20, August 2010, Taj Residency (M.G. Road), Bangalore, India
"Improving clinical practice & trial success rates with improved technologies,
strategies & alliance management"
Conference Info:

Clinical trials in India are finally becoming transparent. There has been a
dramatic increase in the number of trials that have got officially registered in
Clinical Trials Registry-India (CTRI). According to records collected by the
Indian Council of Medical Research and the Drug Controller General's office,
between July-December 2007, only 11 trials were registered. The number increased
to 137 between Jan-Dec 2008 and then to an all-time high of 546 between Jan-Dec
2009. This year, while January saw 58 trials registered, February recorded 60.
India has all the competitive advantages for conducting clinical trials. As the
country is increasingly becoming a favoured destination for clinical trials, a
gap analysis needs to be done to scale up all resources for clinical trials.
This scale up is essential for India to cope with the large global clinical
trial projects. It is no coincidence over the last decade or more of economic
liberalization, and years of unprecedented growth, that India and parts of South
Asia are becoming a preferred clinical research destination for multinational
pharmaceutical and biotechnology corporations.

CTAS 2010 will examine the current issues faced in clinical trials operations,
addressing the risks, timeline and budget stipulations, while effectively
tackling key challenges in overcoming trials agreement and site contract
arbitration problems. This summit will discuss the operational element of trial
site management, strategic partnership with CROs and SMOs, patient, talent &
investigators management in order to improve & optimise the overall drug
development effectiveness and ROI. Discover on how to implement and benefit from
electronic data management & monitoring cost effectively. This conference will
be shared by leading industrial practitioners across the region to promote
practical discussions; especially on the know-how to manage needs, variability
of different countries and institutions to enhance clinical operational
excellence and vigilance. Attendees will have the chance to learn, network and
benchmark against the global top pharmas and local industry leaders on the best
practices in talent, site, budget and performance management in clinical trials.
The conference aims to provide a detailed analysis of what it takes to conduct
clinical trials from a biopharmaceuticals and vaccines perspective in India and
China and also addressing risk/benefit balance, anecdotal experiences of the
multinational pharmaceutical industry in India and China, selection and role of
CROs, logistics of operations, clinical trials management, government policies
and pharmacovigilance.

CTAS 2010 will provide you with the data that you need to recognize this complex
and rapidly-expanding sector. Knowing the future market, and what impact will
that have on future business opportunities? This is your opportunity to stay
ahead by learning the latest trends and networking with the trend setters. It
gives us immense pleasure in welcoming you to the Clinical Trials Asia Summit
'2010.
Key Speakers Include:

Akhilesh Sharma, Vice President &
Global head Clinical management & Global Pharmacovigilance, Dr. Reddy’s,
Bakulesh Khamar, Executive Director – Research Cadila,
Deven Parmar Vice President - Clinical Research & Pharmacovigilance,
Wockhardt,
Shashidhar Rao, India Operations Head (IID and IA&R), Novartis,
Mohan Bangalore, Senior Director & Site Head, Pfizer,
Parminder Kaur, Managing Director, RegPak BioPharma, Consulting,
(Netherlands),
Ramesh Jagannathan, Director-Clinical Research, AstraZeneca,
Deepti Sanghavi, Medical Advisor- Clinical Research, Wockhardt Limited,
Arun Bhatt, President, Clininvent Research,
Milind Antani, Head-Pharma LifeSciences group, Nishith Desai, Associates,
Sanjay Zodpey, Director, Indian Institute of Public Health,
S.K.Bhattacharya, Medical Officer, Depart of Communicable Diseases, WHO
(World Health Organisation),
Shailesh Mehta, Director Clinical R&D and Med Affairs, South Asia,
Glaxosmithkline,
Roopa Basrur, Associate Director - Clinical Writing and Document, Quality,
Pfizer,
Yamin ’Mo’ Khan, Executive Vice President, Clinical Development Pharma-Olam (U.K),
Marcus Hompesch, President – CEO,  Clinical Research, (USA),
Larisa Nagra Singh, General Manager and Project Director, Voisin Consulting
Life Science,
Darshan Bhatt, Consultant, Patient Safety and Pharmacovigilance,
Mala Srivastava, Partner, Nextvel Consulting,
R Ezhil Arasan, Managing Director, VRE Research Laboratories,
(Former Head of Medical Affairs & Differentiated Products, Development at
Dr.Reddy's)
Key Themes Discussed at this
conference:

• Current trends of clinical trials environment.

• How can you take advantage of the global market for clinical trials?

• Discovering technologies and strategies for successful clinical trial
  management.

• Analyzing the successes and challenges of Phase I and Phase II clinical
  trials.

• Setting up clinical trial research hub & techniques for applying risk
  management principles.

• Discover how to improve your supplier-client relationships.

• Complete trials on schedule & budget by overcoming hurdles in
  investigator/patient recruitment.

• Avoiding potential pitfalls of trials agreement.

• Gather the latest regulatory updates impacting global and Indian clinical
  development.

• Explore innovative strategies for outsourcing, what should you be looking
  for in a CRO?

• Improving and optimizing site management and overall productivity of
  clinical operations.

• Data management, CMC SCM, operational requirements & CRO infrastructure in
  India & South Asia.

• Optimising clinical trials operation effectiveness and ROI through strategic
  site, patient, data and risk management in the regulated markets.

• What are the issues with off-shoring trials to countries such as India &
  South Asia? – Solutions?

• Working with limited budget to ensure on time study completion.

• Motivating and managing clinical project teams to improve timeline and
  progress.

• Exploring the efficacy and safety of new interventions in clinical trials.

• Drawing and retaining clinical talent pool to minimise turnover in clinical
  studies.

• Next generation of clinical trials – How big will the market be?

   

   

  To know more and to buy a copy of your report feel free to visit :

  http://www.bharatbook.com/detail.asp?id=144475&rt=Conference-on-Clinical-Trials-Asia-Summit-20101.html

  Or

  Contact us at :

  Bharat Book Bureau
  Tel: +91 22 27578668
  Fax: +91 22 27579131
  Email: info@bharatbook.com
  Website: www.bharatbook.com
  Follow us on twitter: http://twitter.com/3bbharatbook